menu toggle

15-18 April, 2024

Discover Cencora at AMCP Annual 2024

Connect with our teams and managed care leaders as we convene in New Orleans at AMCP 2024 to discuss cutting-edge research, emerging trends, and key insights into tomorrow’s innovations.

Meet with us at booth #613
About-us-callout-3

Schedule a meeting at the conference

About-us-callout-3
Our consultants cover diverse expertise–reimbursement strategy, payer insights, stakeholder engagement, field support–aiding biopharma partners in optimizing product value for market access.

Book a meeting with our experts to explore how our life-cycle solutions drive value and access.
About-us-callout-3

Discover our thought leadership sessions

Educational session

5.0… and Beyond! The Evolution of the AMCP Format for Formulary Submissions

Date: Tuesday 16 April, 2024
Time: 8:30am – 9:45am
Speakers: Adam Hoye-Simek, Ben Penley

Snack and learn session

The Role of Pre-approval Dossiers in a Successful Product Launch

Date: Wednesday 17 April, 2024
Time: 2:00pm – 2:45pm
Speaker: Elham Heidari, Ben Penley, Jasmine Knight, Thai Young, Thomas Liberta

Don’t miss our award-winning research during the Expo

Tuesday, April 16 | 11:00am – 6:00pm and Wednesday, April 17 | 9:00am – 2:30pm

  • Changes in US payer biosimilar coverage policies of granulocyte colony stimulating factor products
  • Early implementation of PIE for specific drug categories
  • Mind the “pre-approval” gap: Payer pre-approval information needs and how manufacturers can better meet them
  • Sourcing value: understanding payer perceptions of value assessment information for formulary decision-making
  • US payer perceptions on formulary evaluation and management of cell and gene therapies
  • Practice efficiencies to healthcare institutions associated with use of epcoritamab vs. other novel therapies in patients with relapsed or refractory follicular lymphoma
  • Payer perspectives of cell therapy and gene therapy treatment paradigms for an inherited retinal disorder
  • Beyond value assessment reports: a review of payer perspectives on ICER’s initiatives and tools

Join our exclusive networking events

Innovations and Impact Award

Tuesday, April 16 | 8:30pm – 9:00pm 

The Innovation and Impact Award recognizes biopharma partners who support HCDM needs for formulary decision making through innovative approaches in digital HCDM engagement via FormularyDecisions. It is awarded annually to one recipient in each of the following categories: mid-to-large biopharma and emerging biopharma. 

FormularyDecisions kiosk

Tuesday, April 16 – Wednesday, April 17

Don't miss out on connecting with our team and visiting our kiosk and photo booth near registration for fun memories from AMCP 2024. 


Afternoon Bubble Tea with FormularyDecisions, an exclusive networking event

amcp

Wednesday, April 17 | 2:00pm – 2:45pm

For healthcare decision makers
amcp
Join FormularyDecisions/Cencora for Bubble Tea while you preview our latest platform updates including the new Cell and Gene Therapy Hub, recent additions to the Clinical Guideline Snapshots and learn more about how your colleagues are leveraging resources including FormularyDecisions in their product review process.
amcp

FormularyDecisions®

Our FormularyDecisions team will be giving live platform demonstrations during the conference. Schedule a live platform demo with our team and see all the ways FormularyDecisions supports the product evaluation process. 

FormularyDecisions delivers unrivaled opportunities for pharma manufacturers to reach out to, and connect with, payers.

  • Increase engagement: Manufacturers who fully take advantage of the FormularyDecisions platform and all its features enjoy greater levels of engagement with the payer community, helping build a stronger level of awareness and relationships with payers.
  • Drive awareness: In the current landscape, it’s harder than ever for manufacturers to get in-person meetings with payers. FormularyDecisions enables easy outreach to, and engagement with, these critical stakeholders.
  • Monitor competition: With unparalleled insights into how their product compares with direct competitors, manufacturers get a full view of the landscape in the therapeutic space, and learn what they can do to stay ahead of the curve.
  • Leverage and understand insights: With direct real-time feedback from payers on a product, manufacturers can get a better understanding of payer perceptions and refine their information so it resonates better with payers

Watch the webinar:

AMCP_logo

Available now: AMCP webinar on-demand

Leveraging the Pre-Approval Information Safe Harbor to Accelerate Patient Access
Watch the webinar for an engaging & informative discussion that dives into the evolving landscape of pre-approval information exchange (PIE).

AMCP hosted a diverse panel of biopharma and market access experts to guide you through valuable insights and strategies for engaging healthcare decision makers with pre-approval information. Explore these opportunities and innovative solutions for leveraging PIE when collaborating with stakeholders.
professionals discussing around computer

Health Economics & Market Access Solutions

Optimize market access, awareness, and outcomes through expert guidance with a proven track record of success. Our leading team of value experts transforms evidence, policy insights, and market intelligence into effective global market access strategies helping clients effectively navigate today’s complex healthcare landscape - Connect with us today!
Xcenda_2_3_Card-02

HTA Quarterly

From therapeutic area spotlights to geographic reviews to critical industry topics, keep current on HTA activity around the globe with HTA Quarterly.

Start a conversation

Our consultative approach and extensive reach across healthcare give us access to the best insights in the industry- insights we leverage to help commercialization challenges for our partners and patients they serve.
meeting